Cardiac-specific deletion of GCN5L1 restricts recovery from ischemia-reperfusion injury.


Journal

Journal of molecular and cellular cardiology
ISSN: 1095-8584
Titre abrégé: J Mol Cell Cardiol
Pays: England
ID NLM: 0262322

Informations de publication

Date de publication:
04 2019
Historique:
received: 03 01 2019
revised: 31 01 2019
accepted: 14 02 2019
pubmed: 19 2 2019
medline: 23 6 2020
entrez: 19 2 2019
Statut: ppublish

Résumé

GCN5L1 regulates mitochondrial protein acetylation, cellular bioenergetics, reactive oxygen species (ROS) generation, and organelle positioning in a number of diverse cell types. However, the functional role of GCN5L1 in the heart is currently unknown. As many of the factors regulated by GCN5L1 play a major role in ischemia-reperfusion (I/R) injury, we sought to determine if GCN5L1 is an important nexus in the response to cardiac ischemic stress. Deletion of GCN5L1 in cardiomyocytes resulted in impaired myocardial post-ischemic function and increased infarct development in isolated work-performing hearts. GCN5L1 knockout hearts displayed hallmarks of ROS damage, and scavenging of ROS restored cardiac function and reduced infarct volume in vivo. GCN5L1 knockdown in cardiac-derived AC16 cells was associated with reduced activation of the pro-survival MAP kinase ERK1/2, which was also reversed by ROS scavenging, leading to restored cell viability. We therefore conclude that GCN5L1 activity provides an important protection against I/R induced, ROS-mediated damage in the ischemic heart.

Identifiants

pubmed: 30776374
pii: S0022-2828(19)30039-2
doi: 10.1016/j.yjmcc.2019.02.009
pmc: PMC6486843
mid: NIHMS1522142
pii:
doi:

Substances chimiques

BLOC1S1 protein, human 0
BLOC1S1 protein, mouse 0
Free Radical Scavengers 0
Mitochondrial Proteins 0
Nerve Tissue Proteins 0
Reactive Oxygen Species 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

69-78

Subventions

Organisme : NHLBI NIH HHS
ID : K22 HL116728
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL132917
Pays : United States
Organisme : NHLBI NIH HHS
ID : R56 HL132917
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL110849
Pays : United States

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Références

Proc Soc Exp Biol Med. 1978 Sep;158(4):658-62
pubmed: 151282
Am J Physiol Cell Physiol. 2004 Oct;287(4):C817-33
pubmed: 15355853
Cardiovasc Res. 2005 Feb 1;65(2):469-77
pubmed: 15639486
J Mol Cell Cardiol. 2005 Jul;39(1):133-47
pubmed: 15913645
Am J Physiol Heart Circ Physiol. 2007 Dec;293(6):H3524-31
pubmed: 17906102
Cardiovasc Drugs Ther. 2009 Aug;23(4):327-31
pubmed: 19466533
Exp Biol Med (Maywood). 2009 Sep;234(9):1011-9
pubmed: 19546346
Apoptosis. 2010 Jun;15(6):669-78
pubmed: 20151195
Methodist Debakey Cardiovasc J. 2009;5(3):2-7
pubmed: 20308957
Biochem J. 2012 May 1;443(3):655-61
pubmed: 22309213
J Mol Cell Cardiol. 2012 Aug;53(2):233-9
pubmed: 22659291
Korean Circ J. 2012 Sep;42(9):600-5
pubmed: 23091504
Int J Mol Med. 2013 Oct;32(4):917-25
pubmed: 23912965
J Biol Chem. 2014 Jan 31;289(5):2864-72
pubmed: 24356961
Cardiovasc Res. 2014 Sep 1;103(4):485-97
pubmed: 24966184
J Mol Cell Cardiol. 2015 Jan;78:80-9
pubmed: 25281838
Toxicol In Vitro. 2015 Aug;29(5):953-61
pubmed: 25835517
Am J Physiol Heart Circ Physiol. 2016 Aug 1;311(2):H347-63
pubmed: 27261364
Circulation. 2017 Mar 7;135(10):e146-e603
pubmed: 28122885
Nat Cell Biol. 2017 Apr;19(4):341-351
pubmed: 28319092
Am J Physiol Heart Circ Physiol. 2017 Aug 1;313(2):H265-H274
pubmed: 28526709
Curr Biol. 2017 Sep 11;27(17):2569-2578.e4
pubmed: 28823680
Nat Commun. 2017 Sep 12;8(1):523
pubmed: 28900165
Cell. 2017 Nov 16;171(5):1110-1124.e18
pubmed: 29033128
Trends Cell Biol. 2018 May;28(5):346-355
pubmed: 29477615
J Biol Chem. 2018 Nov 16;293(46):17676-17684
pubmed: 30323061
J Cell Sci. 2018 Nov 20;131(22):
pubmed: 30333138

Auteurs

Janet R Manning (JR)

Division of Cardiology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, United States; Vascular Medicine Institute, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, United States; Center for Metabolism and Mitochondrial Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, United States.

Dharendra Thapa (D)

Division of Cardiology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, United States; Vascular Medicine Institute, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, United States; Center for Metabolism and Mitochondrial Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, United States.

Manling Zhang (M)

Division of Cardiology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, United States; Vascular Medicine Institute, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, United States; Center for Metabolism and Mitochondrial Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, United States.

Michael W Stoner (MW)

Division of Cardiology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, United States; Vascular Medicine Institute, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, United States; Center for Metabolism and Mitochondrial Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, United States.

Javier Traba (J)

Laboratory of Mitochondrial Biology and Metabolism, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, United States.

Charles F McTiernan (CF)

Division of Cardiology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, United States; Vascular Medicine Institute, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, United States.

Catherine Corey (C)

Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA, United States; Vascular Medicine Institute, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, United States; Center for Metabolism and Mitochondrial Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, United States.

Sruti Shiva (S)

Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA, United States; Vascular Medicine Institute, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, United States; Center for Metabolism and Mitochondrial Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, United States.

Michael N Sack (MN)

Laboratory of Mitochondrial Biology and Metabolism, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, United States.

Iain Scott (I)

Division of Cardiology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, United States; Vascular Medicine Institute, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, United States; Center for Metabolism and Mitochondrial Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, United States. Electronic address: scotti2@upmc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH